These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 29307364)

  • 1. Brain metastases: neuroimaging.
    Pope WB
    Handb Clin Neurol; 2018; 149():89-112. PubMed ID: 29307364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in evaluation of primary brain tumors.
    Chen W; Silverman DH
    Semin Nucl Med; 2008 Jul; 38(4):240-50. PubMed ID: 18514080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of advanced neuroimaging techniques for brain metastases.
    Nowosielski M; Radbruch A
    Chin Clin Oncol; 2015 Jun; 4(2):23. PubMed ID: 26112809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroimaging in brain tumors].
    Arbizu J; Domínguez PD; Diez-Valle R; Vigil C; García-Eulate R; Zubieta JL; Richter JA
    Rev Esp Med Nucl; 2011; 30(1):47-65. PubMed ID: 21211868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain metastases detectability of routine whole body (18)F-FDG PET and low dose CT scanning in 2502 asymptomatic patients with solid extracranial tumors.
    Bochev P; Klisarova A; Kaprelyan A; Chaushev B; Dancheva Z
    Hell J Nucl Med; 2012; 15(2):125-9. PubMed ID: 22741148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
    Barabasch A; Kraemer NA; Ciritsis A; Hansen NL; Lierfeld M; Heinzel A; Trautwein C; Neumann U; Kuhl CK
    Invest Radiol; 2015 Jun; 50(6):409-15. PubMed ID: 25763526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group.
    Galldiks N; Kaufmann TJ; Vollmuth P; Lohmann P; Smits M; Veronesi MC; Langen KJ; Rudà R; Albert NL; Hattingen E; Law I; Hutterer M; Soffietti R; Vogelbaum MA; Wen PY; Weller M; Tonn JC
    Neuro Oncol; 2024 Jul; 26(7):1181-1194. PubMed ID: 38466087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging (PET) of brain tumors.
    Basu S; Alavi A
    Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging challenges of immunotherapy and targeted therapy in patients with brain metastases: response, progression, and pseudoprogression.
    Galldiks N; Kocher M; Ceccon G; Werner JM; Brunn A; Deckert M; Pope WB; Soffietti R; Le Rhun E; Weller M; Tonn JC; Fink GR; Langen KJ
    Neuro Oncol; 2020 Jan; 22(1):17-30. PubMed ID: 31437274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brain metastases imaging].
    Delmaire C; Savatovsky J; Boulanger T; Dhermain F; Le Rhun E; Météllus P; Gerber S; Carsin-Nicole B; Petyt G
    Cancer Radiother; 2015 Feb; 19(1):16-9. PubMed ID: 25649387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT: will it change the way that we use CT in cancer imaging?
    Hicks RJ; Ware RE; Lau EW
    Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain tumors.
    Goldman S; Pirotte BJ
    Methods Mol Biol; 2011; 727():291-315. PubMed ID: 21331940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Update on the Approach to the Imaging of Brain Tumors.
    Mullen KM; Huang RY
    Curr Neurol Neurosci Rep; 2017 Jul; 17(7):53. PubMed ID: 28516376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of PET in brain tumors.
    Chen W
    J Nucl Med; 2007 Sep; 48(9):1468-81. PubMed ID: 17704239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality assessment of brain tumors and tumor recurrence.
    Heiss WD; Raab P; Lanfermann H
    J Nucl Med; 2011 Oct; 52(10):1585-600. PubMed ID: 21840931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging.
    Fink JR; Muzi M; Peck M; Krohn KA
    J Nucl Med; 2015 Oct; 56(10):1554-61. PubMed ID: 26294301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of tumor progression and radiation-induced effects after intracranial radiosurgery.
    Chernov MF; Ono Y; Abe K; Usukura M; Hayashi M; Izawa M; Diment SV; Ivanov PI; Muragaki Y; Iseki H; Hori T; Okada Y; Takakura K
    Acta Neurochir Suppl; 2013; 116():193-210. PubMed ID: 23417479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and Functional Neuroradiology of Brain Metastases.
    Grazzini I; Venezia D; Del Roscio D; Chiarotti I; Mazzei MA; Cerase A
    Semin Ultrasound CT MR; 2023 Jun; 44(3):170-193. PubMed ID: 37245883
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.